StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Filana Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$45.97M. For fiscal 2025 it was -$95.39M. The highest annual figure on record is $31.37M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$95.39M–
FY2024Dec 31, 2024-$141.45M–
FY2023Dec 31, 2023-$105.96M–
FY2022Dec 31, 2022-$80.02M–
FY2021Dec 31, 2021-$32.87M–
FY2020Dec 31, 2020-$6.45M–
FY2019Dec 31, 2019-$4.96M–
FY2018Dec 31, 2018-$6.66M–
FY2017Dec 31, 2017-$11.95M–
FY2016Dec 31, 2016-$14.96M–
FY2015Dec 31, 2015-$14.20M–
FY2014Dec 31, 2014-$12.43M-139.6%
FY2013Dec 31, 2013$31.37M–
FY2012Dec 31, 2012-$3.90M–
FY2011Dec 31, 2011-$3.51M–
FY2010Dec 31, 2010-$13.70M–
FY2009Dec 31, 2009-$6.75M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.39M–
Q1 FY2026Mar 31, 2026-$11.17M–
Q4 FY2025Dec 31, 2025-$13.55M–
Q3 FY2025Sep 30, 2025-$11.86M–
Q2 FY2025Jun 30, 2025-$45.39M–
Q1 FY2025Mar 31, 2025-$24.59M–
Q4 FY2024Dec 31, 2024-$29.49M–
Q3 FY2024Sep 30, 2024-$30.62M–
Q2 FY2024Jun 30, 2024-$61.40M–
Q1 FY2024Mar 31, 2024-$19.93M–
Q4 FY2023Dec 31, 2023-$22.79M–
Q3 FY2023Sep 30, 2023-$27.88M–
Q2 FY2023Jun 30, 2023-$28.78M–
Q1 FY2023Mar 31, 2023-$26.51M–
Q4 FY2022Dec 31, 2022-$20.94M–
Q3 FY2022Sep 30, 2022-$21.35M–
Q2 FY2022Jun 30, 2022-$19.92M–
Q1 FY2022Mar 31, 2022-$17.82M–
Q4 FY2021Dec 31, 2021-$14.44M–
Q3 FY2021Sep 30, 2021-$9.75M–
Q2 FY2021Jun 30, 2021-$5.14M–
Q1 FY2021Mar 31, 2021-$3.53M–
Q4 FY2020Dec 31, 2020-$2.62M–
Q3 FY2020Sep 30, 2020-$1.44M–
Q2 FY2020Jun 30, 2020-$1.16M–
Q1 FY2020Mar 31, 2020-$1.22M–
Q4 FY2019Dec 31, 2019-$1.58M–
Q3 FY2019Sep 30, 2019-$779.00K–
Q2 FY2019Jun 30, 2019-$1.15M–
Q1 FY2019Mar 31, 2019-$1.45M–
Q4 FY2018Dec 31, 2018-$750.00K–
Q3 FY2018Sep 30, 2018-$1.28M–
Q2 FY2018Jun 30, 2018-$2.46M–
Q1 FY2018Mar 31, 2018-$2.17M–
Q4 FY2017Dec 31, 2017-$2.42M–
Q3 FY2017Sep 30, 2017-$2.60M–
Q2 FY2017Jun 30, 2017-$4.17M–
Q1 FY2017Mar 31, 2017-$2.76M–
Q4 FY2016Dec 31, 2016-$2.54M–
Q3 FY2016Sep 30, 2016-$3.54M–

More Filana Therapeutics figures

See a number that looks wrong?